NR1H3 and metabolic dysfunction-associated steatotic liver disease: Furthermore, LXR is also a potent stimulator of fatty acid and triglyceride synthesis, and activation of LXRα in liver is closely related to the development of non-alcoholic fatty liver disease [20,21].